Litcius/Paper detail

Medication Review in Preventing Older Adults’ Fall-Related Injury: a Systematic Review & Meta-Analysis

Yu Ming, Aleksandra Zecevic, Susan Hunter, Wenxin Miao, Rommel G. Tirona

2021Canadian Geriatrics Journal44 citationsDOIOpen Access PDF

Abstract

Background Medication review is essential in managing adverse drug reactions and improving drug safety in older adults. This systematic review evaluated medication review’s role as a single intervention or combined with other interventions in preventing fall-related injuries in older adults. Methods Electronic databases search was conducted in PubMed, EMBASE, Scopus, and CINAHL. Two reviewers screened titles and abstracts, reviewed full texts, and performed data extraction and risk of bias assessment. Meta-analyses were conducted on studies with similar participants, interventions, outcomes or settings. Results Fourteen randomized, controlled studies were included. The pooled results indicated that medication review as a stand-alone intervention was effective in preventing fall-related injuries in community-dwelling older adults (Risk Difference [RD] = -0.06, 95% CI: [-0.11, -0.00], I2 = 61%, p = .04). Medication review also had a positive impact on decreasing the risk of fall-related fractures (RD = -0.02, 95% CI: [-0.04, -0.01], I2 = 0%, p = .01). Discussion This systematic review and meta-analysis has demonstrated that medication review is effective in preventing fall-related injuries in general, and fractures specifically, in community-dwelling older adults. Future investigations focusing on the process of performing medication review will further inform fall-related injury prevention for older adults.

Topics & Concepts

MedicineCINAHLPsychological interventionMeta-analysisScopusMEDLINEFall preventionSystematic reviewAdverse effectPoison controlInjury preventionRandomized controlled trialFalls in older adultsData extractionPhysical therapyEmergency medicineInternal medicinePsychiatryLawPolitical scienceBalance, Gait, and Falls PreventionPharmaceutical Practices and Patient OutcomesPharmacovigilance and Adverse Drug Reactions